Johnson & Johnson has its first regulatory approval for FcRn blocker Imaavy, getting a green light in the US for the would-be blockbuster as a treatment for generalised myasthenia gravis (gMG). It isn ...
Swiss franc strength; USD/CHF lower Pound recovery; GBP/CHF target hit SNB steady; CHF outlook firmer UBS Sees USD/CHF Sliding Below 0.80 in 2026 as SNB Holds Tight; Recommends Locking In GBP/CHF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results